Publicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (5)

2022

  1. Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 9, pp. 2367-2374.e3

2021

  1. Minimal residual disease in Myeloma: Application for clinical care and new drug registration

    Clinical Cancer Research, Vol. 27, Núm. 19, pp. 5195-5212

2018

  1. Encompassing new use cases - Level 3.0 of the HUPO-PSI format for molecular interactions

    BMC Bioinformatics, Vol. 19, Núm. 1

2008

  1. Human Proteinpedia enables sharing of human protein data [4]

    Nature Biotechnology

2007

  1. The minimum information required for reporting a molecular interaction experiment (MIMIx)

    Nature Biotechnology, Vol. 25, Núm. 8, pp. 894-898